SARS-CoV-2 3CLpro-IN-28
SARS-CoV-2 3CLpro-IN-28 (Compound 19) is an inhibitor for SARS-CoV-2 3CLpro with an IC50 of 0.018 μM[1].
Product Specifications
CAS Number
2603242-35-7
UNSPSC
12352005
Target
SARS-CoV; Virus Protease
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C1C(C2=CN(C3=CN=CC=C3)C(C(C4=CC(Cl)=CC(OCC5=CC=CC=C5Cl)=C4)=C2)=O)=CNC(N1)=O
Molecular Formula
C27H18Cl2N4O4
Molecular Weight
533.36
References & Citations
[1]Banerjee S, et al., Exploring the key structural attributes and chemico-biological interactions of pyridinone-based SARS-CoV-2 3CLpro inhibitors through validated structure-based drug design strategies. Heliyon. 2024 Nov 15;10 (23) :e40404.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC401037-500 1x 500 µL
CD44 Standard (DF1485), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC421440 20 µg
G protein alpha S (GNAS) (NM_001077489) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC471171-100 1x 100 µL
CD34 (HPCA1/1171), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details